10x Genomics, Inc. (TXG): Revenue
$642.82M
Year ended 2025-12-31
$616.91M
Trailing 12 months to 2026-06-30
+7.6%
3-year compound annual growth
+16.6%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $642.82M | +5.2% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $610.78M | -1.3% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $618.73M | +19.8% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $516.41M | +5.3% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $490.49M | +64.1% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $298.85M | +21.5% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $245.89M | +68.1% | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | $146.31M | +105.8% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $71.08M | n/a | 2020-02-27, From 2017-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $642.82M | +5.2% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $201.49M | +0.5% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $160.00M | +3.9% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $2.58B | +0.7% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $2.86B | +3.7% |
| Quanterix Corp (QTRX) | 2025-12-31 | $138.90M | +1.1% |
| Waters Corp (WAT) | 2025-12-31 | $3.17B | +7.0% |
| Bruker Corp (BRKR) | 2025-12-31 | $3.44B | +2.1% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $4.03B | +4.0% |
Compare TXG, CTKB, PACB, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗